Search Result "Lu-177."
Consequences of meta-stable 177mLu admixture in 177Lu for patient dosimetry
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 145-149
Author(s): Mark W. Konijnenberg
Alternative method to determine Specific Activity of 177Lu by HPLC
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 119-122
Author(s): Wouter A. P. Breeman,Rory M. S. de Zanger,Ho Sze Chan,Erik de Blois
Radiation Dosimetry Aspects of 177Lu
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 139-144
Author(s): Michael Lassmann,Uta Eberlein
177Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 85-93
Author(s): Henia Balter,Trindade Victoria,Terán Mariella,Gaudiano Javier,Ferrando Rodolfo,Paolino Andrea,Rodriguez Graciela,Hermida Juan,De Marco Eugenia,Oliver Patricia
Pharmacokinetic, Dosimetry and Toxicity Study of 177Lu-EDTMP in Patients: Phase 0/I study
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 71-84
Author(s): Chandrasekhar Bal,Geetanjali Arora,Praveen Kumar,Nishikant Damle,Tapas Das,Sudipta Chakraborty,Sharmila Banerjee,Meera Venkatesh,John J. Zaknun,M. R.A. Pillai
Investigation of Radiolabeling Efficacy by Enhancement of the Chemicalform of no Carrier Added 177Lu Isolated by Electro Amalgamation Process
Journal: Current Radiopharmaceuticals
Volume: 15 Issue: 1 Year: 2022 Page: 56-62
Author(s): Sara Vosoughi,Nafise Salek,Simindokht Shirvani Arani,Ali Bahrami Samani,Mohammad Ghannadi Maragheh
Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 8-18
Author(s): Wouter A.P. Breeman,Ho Sze Chan,Rory M.S. de Zanger,Mark K. Konijnenberg,Erik de Blois
Comparison of Two Types of Amino Acid Solutions on 177Lu-DotatatePharmacokinetics and Pharmacodynamics in Patients with Metastatic GastroenteropancreaticNeuroendocrine Tumors
Journal: Current Radiopharmaceuticals
Volume: 15 Issue: 2 Year: 2022 Page: 164-172
Author(s):
Indirect Production of No Carrier Added (NCA) 177Lu from Irradiation of Enriched 176Yb: Options for Ytterbium/Lutetium Separation
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 107-118
Author(s): Ashutosh Dash,Rubel Chakravarty,Furn F. (Russ) Knapp,Ambikalmajan M.R. Pillai
177Lu-PSMA-617 Radioligand Treatment in Elderly Patients with MetastaticCastration-resistant Prostate Cancer: Therapeutic Efficacy and SafetyAssessment
Journal: Current Radiopharmaceuticals
Volume: 17 Issue: 4 Year: 2024 Page: 356-363
Author(s):